NO20021832L - Farmasöytiske sammensetninger av tizoksanid og nitazoksanid - Google Patents

Farmasöytiske sammensetninger av tizoksanid og nitazoksanid

Info

Publication number: NO20021832L
Authority: NO; Norway
Prior art keywords: tizoxanide; nitazoxanide; pharmaceutical compositions; pharmaceutical; compositions
Prior art date: 1997-05-07

Application number

NO20021832A

Other languages

English (en)

Other versions

NO335781B1 (no

NO20021832D0 (no

Inventor

Jean-Francois Rossignol

Original Assignee

Romark Lab Lc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-05-07

Filing date

2002-04-18

Publication date

2000-01-04

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27420362&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20021832(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1997-05-07 Priority claimed from US08/852,447 external-priority patent/US5968961A/en

1997-07-03 Priority claimed from US08/887,810 external-priority patent/US5856348A/en

1997-07-03 Priority claimed from US08/887,809 external-priority patent/US5965590A/en

2000-01-04 Publication of NO20021832L publication Critical patent/NO20021832L/no

2002-04-18 Application filed by Romark Lab Lc filed Critical Romark Lab Lc

2002-04-18 Publication of NO20021832D0 publication Critical patent/NO20021832D0/no

2015-02-16 Publication of NO335781B1 publication Critical patent/NO335781B1/no

Links

FDTZUTSGGSRHQF-UHFFFAOYSA-N Desacetyl-nitazoxanide Chemical group OC1=CC=CC=C1C(=O)NC1=NC=C([N+]([O-])=O)S1 FDTZUTSGGSRHQF-UHFFFAOYSA-N 0.000 title 1
YQNQNVDNTFHQSW-UHFFFAOYSA-N acetic acid [2-[[(5-nitro-2-thiazolyl)amino]-oxomethyl]phenyl] ester Chemical compound CC(=O)OC1=CC=CC=C1C(=O)NC1=NC=C([N+]([O-])=O)S1 YQNQNVDNTFHQSW-UHFFFAOYSA-N 0.000 title 1
229960002480 nitazoxanide Drugs 0.000 title 1
239000008194 pharmaceutical composition Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
- A61P33/12—Schistosomicides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Immunology (AREA)
Communicable Diseases (AREA)
Tropical Medicine & Parasitology (AREA)
Oncology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Virology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

NO20021832A 1997-05-07 2002-04-18 Farmasøytiske sammensetninger av tizoksanid og nitazoksanid NO335781B1 (no)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
US08/852,447 US5968961A (en)	1997-05-07	1997-05-07	Pharmaceutical compositions of tizoxanide and nitazoxanide
US08/887,810 US5856348A (en)	1994-09-08	1997-07-03	Method for treatment of trematodes with pharmaceutical compositions of tizoxanide and nitazoxanide
US08/887,809 US5965590A (en)	1994-09-08	1997-07-03	Method for treatment of opportunistic infections with pharmaceutical compositions of tizoxanide and nitazoxanide
PCT/US1998/009229 WO1998050035A1 (en)	1997-05-07	1998-05-06	Pharmaceutical compositions of tizoxanide and nitazoxanide

Publications (3)

Publication Number	Publication Date
NO20021832L true NO20021832L (no)	2000-01-04
NO20021832D0 NO20021832D0 (no)	2002-04-18
NO335781B1 NO335781B1 (no)	2015-02-16

Family

ID=27420362

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
NO19995406A NO313983B1 (no)	1997-05-07	1999-11-04	Farmasöytiske sammensetninger av tizoksanid og nitazoksanid
NO20021832A NO335781B1 (no)	1997-05-07	2002-04-18	Farmasøytiske sammensetninger av tizoksanid og nitazoksanid

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
NO19995406A NO313983B1 (no)	1997-05-07	1999-11-04	Farmasöytiske sammensetninger av tizoksanid og nitazoksanid

Country Status (34)

Country	Link
EP (2)	EP1222921B1 (no)
JP (1)	JP3739802B2 (no)
KR (2)	KR100576646B1 (no)
CN (2)	CN100515420C (no)
AP (1)	AP1103A (no)
AR (1)	AR057242A2 (no)
AT (2)	ATE281166T1 (no)
AU (1)	AU740022B2 (no)
BG (2)	BG109365A (no)
BR (1)	BR9808722A (no)
CA (2)	CA2288003C (no)
CZ (2)	CZ298270B6 (no)
DE (2)	DE69809928T2 (no)
DK (2)	DK1005342T3 (no)
EA (2)	EA002908B1 (no)
EE (1)	EE04870B1 (no)
ES (2)	ES2232687T3 (no)
GE (1)	GEP20032970B (no)
HU (1)	HU229641B1 (no)
IL (2)	IL132516A (no)
IS (1)	IS2087B (no)
LV (1)	LV12492B (no)
ME (1)	ME00530B (no)
NO (2)	NO313983B1 (no)
NZ (2)	NZ513881A (no)
OA (1)	OA11169A (no)
PL (1)	PL193275B1 (no)
PT (2)	PT1005342E (no)
RO (1)	RO120605B1 (no)
SI (1)	SI20149B (no)
SK (2)	SK283947B6 (no)
TR (1)	TR199902733T2 (no)
UA (2)	UA57079C2 (no)
WO (1)	WO1998050035A1 (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2467321A1 (en)	2004-05-14	2005-11-14	Paul J. Santerre	Polymeric coupling agents and pharmaceutically-active polymers made therefrom
MX2008008723A (es) *	2006-01-09	2008-09-26	Romark Lab Lc	Tratamiento de la hepatitis viral.
MX381895B (es) *	2009-02-13	2025-03-13	Romark Laboratories Lc	Formulaciones farmaceuticas de liberacion controlada de nitazoxanida.
CN105853415A (zh)	2009-05-12	2016-08-17	罗马克实验室有限公司	卤代烷基杂芳基苯甲酰胺化合物
BRPI1014322A2 (pt)	2009-06-26	2015-08-25	Romark Lab Lc	Método para tratar infecção, e para interromper ou evitar a produção de partículas virais infecciosas, combinação, e, composição farmacêutica.
US9498441B2 (en)	2012-01-27	2016-11-22	Siegfried Rhein S.A. De C.V.	Nitazoxadine composition and process to prepare same
JP6633092B2 (ja) *	2014-11-11	2020-01-22	ロマークラボラトリーズ，リミティドカンパニー	チゾキサニド、その類似体又は塩のプロドラッグを用いる組成物及び治療方法
EP3740494A4 (en)	2018-02-02	2021-11-03	Ripple Therapeutics Corporation	GLASS FORMULATIONS WITH STEROID DIMERS AND USES THEREOF
WO2019241376A1 (en)	2018-06-14	2019-12-19	The Trustees Of Columbia University In The City Of New York	Treatment of cognitive disorders using nitazoxanide (ntz), nitazoxanide (ntz) analogs, and metabolites thereof
WO2020154815A1 (en)	2019-02-01	2020-08-06	Ripple Therapeutics Corporation	Crystalline forms of dexamethasone dimers and uses thereof
US12509469B2 (en)	2019-08-07	2025-12-30	Ripple Therapeutics Corporation	Compositions and methods for the treatment of pain and dependence disorders
CA3176134A1 (en)	2020-05-01	2021-11-04	Ripple Therapeutics Corporation	Heterodimer compositions and methods for the treatment of ocular disorders
WO2022130406A1 (en) *	2020-12-15	2022-06-23	Cipla Limited	Inhalation composition of nitazoxanide or its derivatives for use in coronavirus disease

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1437800A (en) *	1973-08-08	1976-06-03	Phavic Sprl	Derivatives of 2-benzamido-5-nitro-thiazoles
US4315018A (en) *	1978-12-07	1982-02-09	Rossignol Jean F	Specific parasiticidal use of 2-benzamido-5-nitro-thiazole derivatives
US5387598A (en) *	1994-04-13	1995-02-07	Rossignol; Jean-Francois	Composition and galenic formulation suitable for combatting affections of the lower abdomen
US5578621A (en) *	1994-09-08	1996-11-26	Romark Lab Lc	Benzamide derivatives

1998
- 1998-05-06 SI SI9820037A patent/SI20149B/sl not_active IP Right Cessation
- 1998-05-06 KR KR1020037011334A patent/KR100576646B1/ko not_active Expired - Fee Related
- 1998-05-06 HU HU0003330A patent/HU229641B1/hu not_active IP Right Cessation
- 1998-05-06 ES ES02002887T patent/ES2232687T3/es not_active Expired - Lifetime
- 1998-05-06 EP EP02002887A patent/EP1222921B1/en not_active Expired - Lifetime
- 1998-05-06 NZ NZ513881A patent/NZ513881A/xx not_active IP Right Cessation
- 1998-05-06 EA EA199901012A patent/EA002908B1/ru not_active IP Right Cessation
- 1998-05-06 NZ NZ500149A patent/NZ500149A/en not_active IP Right Cessation
- 1998-05-06 SK SK708-2003A patent/SK283947B6/sk unknown
- 1998-05-06 AU AU72895/98A patent/AU740022B2/en not_active Ceased
- 1998-05-06 CN CNB2004100459536A patent/CN100515420C/zh not_active Expired - Fee Related
- 1998-05-06 GE GEAP19985109A patent/GEP20032970B/en unknown
- 1998-05-06 SK SK1511-99A patent/SK283946B6/sk unknown
- 1998-05-06 AP APAP/P/1999/001675A patent/AP1103A/en active
- 1998-05-06 AT AT02002887T patent/ATE281166T1/de active
- 1998-05-06 DK DK98920285T patent/DK1005342T3/da active
- 1998-05-06 CN CNB988049007A patent/CN1158074C/zh not_active Expired - Fee Related
- 1998-05-06 ME MEP-2008-877A patent/ME00530B/me unknown
- 1998-05-06 WO PCT/US1998/009229 patent/WO1998050035A1/en not_active Ceased
- 1998-05-06 IL IL13251698A patent/IL132516A/xx not_active IP Right Cessation
- 1998-05-06 JP JP54843798A patent/JP3739802B2/ja not_active Expired - Fee Related
- 1998-05-06 CA CA002288003A patent/CA2288003C/en not_active Expired - Fee Related
- 1998-05-06 EE EEP199900578A patent/EE04870B1/xx unknown
- 1998-05-06 CA CA002418634A patent/CA2418634C/en not_active Expired - Fee Related
- 1998-05-06 AT AT98920285T patent/ATE228839T1/de active
- 1998-05-06 PT PT98920285T patent/PT1005342E/pt unknown
- 1998-05-06 EA EA200100956A patent/EA002920B1/ru not_active IP Right Cessation
- 1998-05-06 CZ CZ20060366A patent/CZ298270B6/cs not_active IP Right Cessation
- 1998-05-06 RO RO99-01166A patent/RO120605B1/ro unknown
- 1998-05-06 DE DE69809928T patent/DE69809928T2/de not_active Expired - Lifetime
- 1998-05-06 KR KR10-1999-7009930A patent/KR100426657B1/ko not_active Expired - Lifetime
- 1998-05-06 EP EP98920285A patent/EP1005342B1/en not_active Expired - Lifetime
- 1998-05-06 PT PT02002887T patent/PT1222921E/pt unknown
- 1998-05-06 TR TR1999/02733T patent/TR199902733T2/xx unknown
- 1998-05-06 BR BR9808722-3A patent/BR9808722A/pt not_active IP Right Cessation
- 1998-05-06 ES ES98920285T patent/ES2150404T3/es not_active Expired - Lifetime
- 1998-05-06 DE DE69827417T patent/DE69827417T2/de not_active Expired - Lifetime
- 1998-05-06 PL PL336805A patent/PL193275B1/pl not_active IP Right Cessation
- 1998-05-06 DK DK02002887T patent/DK1222921T3/da active
- 1998-05-06 IL IL15579998A patent/IL155799A/en not_active IP Right Cessation
- 1998-05-06 CZ CZ0391199A patent/CZ298269B6/cs not_active IP Right Cessation
- 1998-06-05 UA UA99126626A patent/UA57079C2/uk unknown
- 1998-12-06 BG BG109365A patent/BG109365A/en unknown
1999
- 1999-10-19 IS IS5223A patent/IS2087B/is unknown
- 1999-10-29 OA OA9900239A patent/OA11169A/en unknown
- 1999-11-04 NO NO19995406A patent/NO313983B1/no not_active IP Right Cessation
- 1999-12-01 LV LVP-99-170A patent/LV12492B/en unknown
- 1999-12-06 BG BG103958A patent/BG64973B1/bg unknown
2002
- 2002-04-18 NO NO20021832A patent/NO335781B1/no not_active IP Right Cessation
2003
- 2003-04-04 UA UA2003042974A patent/UA74388C2/uk unknown
2006
- 2006-12-14 AR ARP060105534A patent/AR057242A2/es not_active Application Discontinuation

Also Published As

Publication number	Publication date
DE69809928T2 (de)	2003-04-24
CN1158074C (zh)	2004-07-21
IS2087B (is)	2006-03-15
NO995406D0 (no)	1999-11-04
NO995406L (no)	2000-01-04
SI20149B (en)	2001-08-31
EP1222921A1 (en)	2002-07-17
EA002920B1 (ru)	2002-10-31
RO120605B1 (ro)	2006-05-30
CA2288003A1 (en)	1998-11-12
DE69827417D1 (de)	2004-12-09
DE69809928D1 (de)	2003-01-16
PL193275B1 (pl)	2007-01-31
BR9808722A (pt)	2000-07-11
DE69827417T2 (de)	2005-10-27
NO335781B1 (no)	2015-02-16
ATE228839T1 (de)	2002-12-15
DK1222921T3 (da)	2005-03-07
ES2232687T3 (es)	2005-06-01
ME00530B (me)	2011-10-10
AU7289598A (en)	1998-11-27
CN1255060A (zh)	2000-05-31
EA002908B1 (ru)	2002-10-31
EP1005342A4 (en)	2001-02-07
IS5223A (is)	1999-10-19
CZ298269B6 (cs)	2007-08-08
JP2001503067A (ja)	2001-03-06
UA57079C2 (uk)	2003-06-16
ATE281166T1 (de)	2004-11-15
JP3739802B2 (ja)	2006-01-25
EA199901012A1 (ru)	2000-08-28
SI20149A (sl)	2000-08-31
HK1025907A1 (en)	2000-12-01
KR20010020322A (ko)	2001-03-15
EE9900578A (et)	2000-08-15
NO20021832D0 (no)	2002-04-18
KR100426657B1 (ko)	2004-04-13
CN100515420C (zh)	2009-07-22
TR199902733T2 (xx)	2000-03-21
EP1005342B1 (en)	2002-12-04
SK283946B6 (sk)	2004-05-04
IL155799A (en)	2004-08-31
LV12492B (en)	2001-01-20
CZ298270B6 (cs)	2007-08-08
CA2288003C (en)	2003-10-21
OA11169A (en)	2003-04-25
HUP0003330A3 (en)	2002-10-28
WO1998050035A1 (en)	1998-11-12
KR20040004544A (ko)	2004-01-13
SK151199A3 (en)	2000-07-11
EP1222921B1 (en)	2004-11-03
CZ391199A3 (cs)	2000-07-12
HUP0003330A2 (hu)	2001-05-28
ES2150404T3 (es)	2003-07-01
NZ500149A (en)	2001-11-30
AR057242A2 (es)	2007-11-21
UA74388C2 (uk)	2005-12-15
PT1005342E (pt)	2003-02-28
AU740022B2 (en)	2001-10-25
BG109365A (en)	2006-08-31
CN1552322A (zh)	2004-12-08
AP9901675A0 (en)	1999-12-31
CA2418634C (en)	2004-10-26
BG64973B1 (bg)	2006-11-30
NZ513881A (en)	2002-10-25
SK283947B6 (sk)	2004-05-04
IL132516A0 (en)	2001-03-19
EP1005342A1 (en)	2000-06-07
CA2418634A1 (en)	1998-11-12
DK1005342T3 (da)	2003-03-24
LV12492A (en)	2000-06-20
PT1222921E (pt)	2005-02-28
IL132516A (en)	2003-12-10
PL336805A1 (en)	2000-07-17
EE04870B1 (et)	2007-08-15
AP1103A (en)	2002-09-04
ES2150404T1 (es)	2000-12-01
GEP20032970B (en)	2003-05-27
KR100576646B1 (ko)	2006-05-08
NO313983B1 (no)	2003-01-13
BG103958A (en)	2000-07-31
EA200100956A1 (ru)	2002-02-28
IL155799A0 (en)	2003-12-23
HU229641B1 (en)	2014-03-28

Legal Events

Date	Code	Title	Description
2017-12-27	MM1K	Lapsed by not paying the annual fees

Publication	Publication Date	Title
LT99141A (lt)	2000-08-25	Tizoksanido ir nitazoksanido farmacinės kompozicijos
BR9607317A (pt)	1997-12-30	Peptídios e composição farmacêutica
BR9607318A (pt)	1997-12-30	Peptidos e composição farmacêutica
IL135589A0 (en)	2001-05-20	Aminothiazole derivatives and pharmaceutical compositions containing the same
HUP9902655A3 (en)	2000-12-28	Pharmaceutical composition of hedgehog proteins and use thereof
NO984094L (no)	1999-03-09	Utladningsreaktor og anvendelse av samme
HUP0100149A3 (en)	2001-12-28	Antipicornaviral peptide derivatives pharmaceutical compositions comprising thereof and their use
HU9800147D0 (en)	1998-03-30	Isoxasol-and crotonoil-amide derivatives and pharmaceutical and diagnostical compositions containing them
NO995406D0 (no)	1999-11-04	Farmasöytiske sammensetninger av tizoksanid og nitazoksanid
HUP0100085A3 (en)	2002-12-28	Biphenylamidine derivatives and pharmaceutical compositions containing them
HUP0002331A3 (en)	2001-05-28	20-aralkyl-5alpha-pregnane derivatives and pharmaceutical compositions thereof
BR9509688A (pt)	1997-09-30	Composto e composição farmacêutica
PT1140110E (pt)	2003-11-28	Clatratos de desidroepiandrosterona e correspondentes composicoes farmaceuticas
FI971427A7 (fi)	1997-05-26	Peptidit ja niitä sisältävät farmaseuttiset koostumukset
NO20001758D0 (no)	2000-04-05	Fremgangsmåter og blandinger for behandling av leddgikt
EP0996441A4 (en)	2002-08-07	PHARMACEUTICAL COMPOSITIONS OF ARGLABIN AND ARGLABIN DERIVATIVES
HUP9900251A3 (en)	2001-01-29	Pharmaceutical compositions containing hedgehog proteins and use of former compositions
ZA995006B (en)	2000-02-07	Pharmaceutical composition of hedgehog proteins and use thereof.
BR9605220A (pt)	1998-07-21	Gonadotropinas e composiçao farmacêutica
BR9505130A (pt)	1997-09-09	Composto e composiçao farmacêutica
BR1100391A (pt)	2002-04-09	Composto e composição farmacêutica
SE9703737D0 (sv)	1997-10-14	Pharmaceutical composition and use
DK1014951T3 (da)	2005-04-04	Farmaceutisk coatingssammensætning og fremgangsmåde til anvendelse
BR1101151A (pt)	2003-08-12	Compostos e composição farmacêutica
ZA99887B (en)	1999-08-04	Pharmaceutical composition of hedgehog proteins and use thereof.